Physician profile
Jasdeep Soni
NPI 1932711553
$26,124.77
in general payments reported to CMS, 2019-2025
12 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $336 · 2022: $129 · 2023: $725 · 2024: $4,643 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,145 · Travel and Lodging: $4,270 · Food and Beverage: $3,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,673.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,145.00 |
| Travel and Lodging | $4,270.43 |
| Food and Beverage | $3,571.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $24,325.29 | 2023-2025 | Total30, Precision7, Dailies Total1 |
| Coopervision INC. | $400.64 | 2023-2024 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $230.10 | 2023-2025 | Infuse, Xiidra, Blink Nutritears |
| Lkc Technologies, INC. | $227.98 | 2023-2024 | |
| Johnson & Johnson Vision Care, INC. | $216.30 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $168.25 | 2021 | |
| Glaukos Corporation | $146.22 | 2024 | Ce-Marked Kxla System |
| Eyevance Pharmaceuticals LLC | $142.41 | 2021 | |
| Biotissue Holdings INC. | $113.62 | 2025 | |
| Genentech USA, INC. | $71.90 | 2022 | |
| Allergan, INC. | $57.00 | 2022 | |
| Dompe US, INC. | $25.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasdeep Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.